Skanditeks subsidiary CMA Microdialysis AB launches system for continuous bedside glucose monitoring
CMA Microdialysis AB (CMA) today announced the launch of the new CE-approved IView Catheter,which enables highly accurate tight glycemic control (TGC) in the Intensive Care Unit (ICU).Skanditek holds 78 percent of it´s subsidiary CMA Microdialysis.As to the rest, we refer to enclosed press release from CMA Microdialysis AB.SKANDITEK INDUSTRIFÖRVALTNING AB (publ)For further information, please contact:Patrik Tigerschiöld, President and CEO,telephone +46-8-614 00 20,Philip Siberg, CEO CMA Microdialysis,mobil +46 70 790 67 43, e-post philip.siberg@microdialysis.se